<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.340">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>hallmarks-of-cancer-1</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="hallmarks-of-cancer-1_files/libs/clipboard/clipboard.min.js"></script>
<script src="hallmarks-of-cancer-1_files/libs/quarto-html/quarto.js"></script>
<script src="hallmarks-of-cancer-1_files/libs/quarto-html/popper.min.js"></script>
<script src="hallmarks-of-cancer-1_files/libs/quarto-html/tippy.umd.min.js"></script>
<script src="hallmarks-of-cancer-1_files/libs/quarto-html/anchor.min.js"></script>
<link href="hallmarks-of-cancer-1_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="hallmarks-of-cancer-1_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="hallmarks-of-cancer-1_files/libs/bootstrap/bootstrap.min.js"></script>
<link href="hallmarks-of-cancer-1_files/libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="hallmarks-of-cancer-1_files/libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">


</head>

<body class="fullcontent">

<div id="quarto-content" class="page-columns page-rows-contents page-layout-article">

<main class="content" id="quarto-document-content">



<p><img src="img%5CHallmarks-of-Cancer-10.jpg" class="img-fluid"></p>
<section id="hallmarks-of-cancer-1" class="level1">
<h1>Hallmarks of Cancer-1</h1>
</section>
<section id="serdar-balci-md" class="level1">
<h1>Serdar BALCI, MD</h1>
<p><img src="img%5CHallmarks-of-Cancer-11.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-12.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-13.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-14.png" class="img-fluid"></p>
<p><strong>Cell. 2000 Jan 7;100(1):57-70.</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-15.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-16.png" class="img-fluid"></p>
<p><span style="color:#FFFFFF"> <em>Cell</em> </span> <span style="color:#FFFFFF">&nbsp;2011 144, 646-674DOI: (10.1016/j.cell.2011.02.013) </span></p>
<p><strong>Cell. 2011 Mar 4;144(5):646-74</strong></p>
<p><span style="color:#FFFFFF">Copyright © 2011 Elsevier Inc.</span> <em><a href="http://www.elsevier.com/termsandconditions">Terms and Conditions</a></em></p>
<p><img src="img%5CHallmarks-of-Cancer-17.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-18.png" class="img-fluid"></p>
<p><span style="color:#FFFFFF"> <em>Cell</em> </span> <span style="color:#FFFFFF">&nbsp;2011 144, 646-674DOI: (10.1016/j.cell.2011.02.013) </span></p>
<p><strong>Cell. 2011 Mar 4;144(5):646-74</strong></p>
<p><span style="color:#FFFFFF">Copyright © 2011 Elsevier Inc.</span> <em><a href="http://www.elsevier.com/termsandconditions">Terms and Conditions</a></em></p>
<p><img src="img%5CHallmarks-of-Cancer-19.png" class="img-fluid"></p>
<p><strong>Cell. 2000 Jan 7;100(1):57-70.</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-110.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-111.png" class="img-fluid"></p>
<p><span style="color:#FFFFFF"> <em>Cell</em> </span> <span style="color:#FFFFFF">&nbsp;2011 144, 646-674DOI: (10.1016/j.cell.2011.02.013) </span></p>
<p><strong>Cell. 2011 Mar 4;144(5):646-74</strong></p>
<p><span style="color:#FFFFFF">Copyright © 2011 Elsevier Inc.</span> <em><a href="http://www.elsevier.com/termsandconditions">Terms and Conditions</a></em></p>
<p><img src="img%5CHallmarks-of-Cancer-112.png" class="img-fluid"></p>
<p><strong>Cell. 2000 Jan 7;100(1):57-70.</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-113.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-114.png" class="img-fluid"></p>
<p><span style="color:#FFFFFF"> <em>Cell</em> </span> <span style="color:#FFFFFF">&nbsp;2011 144, 646-674DOI: (10.1016/j.cell.2011.02.013) </span></p>
<p><strong>Cell. 2011 Mar 4;144(5):646-74</strong></p>
<p><span style="color:#FFFFFF">Copyright © 2011 Elsevier Inc.</span> <em><a href="http://www.elsevier.com/termsandconditions">Terms and Conditions</a></em></p>
<p><img src="img%5CHallmarks-of-Cancer-115.png" class="img-fluid"></p>
<p><strong>Cell. 2000 Jan 7;100(1):57-70.</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-116.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-117.png" class="img-fluid"></p>
<p><span style="color:#FFFFFF"> <em>Cell</em> </span> <span style="color:#FFFFFF">&nbsp;2011 144, 646-674DOI: (10.1016/j.cell.2011.02.013) </span></p>
<p><strong>Cell. 2011 Mar 4;144(5):646-74</strong></p>
<p><span style="color:#FFFFFF">Copyright © 2011 Elsevier Inc.</span> <em><a href="http://www.elsevier.com/termsandconditions">Terms and Conditions</a></em></p>
<p><img src="img%5CHallmarks-of-Cancer-118.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-119.png" class="img-fluid"></p>
<p><span style="color:#FFFFFF"> <em>Cell</em> </span> <span style="color:#FFFFFF">&nbsp;2011 144, 646-674DOI: (10.1016/j.cell.2011.02.013) </span></p>
<p><strong>Cell. 2011 Mar 4;144(5):646-74</strong></p>
<p><span style="color:#FFFFFF">Copyright © 2011 Elsevier Inc.</span> <em><a href="http://www.elsevier.com/termsandconditions">Terms and Conditions</a></em></p>
</section>
<section id="section" class="level1">
<h1></h1>
<p><strong>http://www.cellsignal.com/common/content/content.jsp?id=science-pathways</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-120.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="hallmarks-of-cancer" class="level1">
<h1>Hallmarks of Cancer</h1>
<p><strong>Self-sufficiency in growth signals</strong></p>
<p><strong>Insensitivity to growth inhibitory signals</strong></p>
<p><strong>Evasion of cell death</strong></p>
<p><strong>Limitless replicative potential</strong></p>
<p><strong>Development of sustained angiogenesis</strong></p>
<p><strong>Ability to invade and metastasize</strong></p>
<p><strong>Genomic instability</strong></p>
<p><strong>Tumor-promoting inflammation</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-121.jpg" class="img-fluid"></p>
</section>
<section id="self-sufficiency-in-growth-signals" class="level1">
<h1>SELF-SUFFICIENCY IN GROWTH SIGNALS</h1>
</section>
<section id="self-sufficiency-in-growth-signals-1" class="level1">
<h1>Self-Sufficiency in Growth Signals</h1>
<ul>
<li><strong>Physiologic Growth</strong>
<ul>
<li><strong>The binding of a growth factor to its specific receptor on the cell membrane</strong></li>
<li><strong>Transient and limited activation of the growth factor receptor, which in turn activates several signal-transducing proteins on the inner leaflet of the plasma membrane</strong></li>
<li><strong>Transmission of the transduced signal across the cytosol to the nucleus by second messengers or a cascade of signal transduction molecules</strong></li>
<li><strong>Induction and activation of nuclear regulatory factors that initiate and regulate DNA transcription</strong></li>
<li><strong>Entry and progression of the cell into the cell cycle, resulting ultimately in cell division</strong></li>
</ul></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-122.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-123.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-124.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-125.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-126.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-127.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-128.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-129.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-130.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-131.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-132.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-133.jpg" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-134.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-135.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-136.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-137.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="growth-factors" class="level1">
<h1>Growth Factors</h1>
<ul>
<li><strong>Cancer cells synthesize the same growth factors to which they are responsive</strong></li>
<li><strong>Glioblastomas</strong>
<ul>
<li><strong>secrete platelet-derived growth factor (PDGF)</strong></li>
<li><strong>express the PDGF receptor</strong></li>
</ul></li>
<li><strong>Sarcomas</strong>
<ul>
<li><strong>Make transforming growth factor-α (TGF-α)</strong></li>
<li><strong>TGF-α receptor</strong></li>
</ul></li>
<li><strong>Interaction with stroma</strong>
<ul>
<li><strong>Tumor cells send signals to activate normal cells in the supporting stroma</strong></li>
<li><strong>Then the stromal cells produce growth factors that promote tumor growth</strong></li>
</ul></li>
</ul>
</section>
<section id="growth-factor-receptors-and-non-receptor-tyrosine-kinases" class="level1">
<h1>Growth Factor Receptors andNon-Receptor Tyrosine Kinases</h1>
<p><strong>Mutant receptor proteins:</strong></p>
<p><strong>Deliver continuous mitogenic signals to cells</strong></p>
<p><strong>Even in the absence of the growth factor in the environment</strong></p>
<ul>
<li><strong>Overexpression of growth factor receptors</strong>
<ul>
<li><strong>Hyperresponsive to levels of the growth factor that would not normally trigger proliferation</strong></li>
</ul></li>
<li><strong>ERBB1 (EGF receptor)</strong>
<ul>
<li><strong>Overexpressed in 80% of squamous cell carcinomas of the lung</strong></li>
<li><strong>50% or more of glioblastomas</strong></li>
<li><strong>80% to 100% of epithelial tumors of the head and neck</strong></li>
</ul></li>
<li><strong>HER2/NEU (ERBB2)</strong>
<ul>
<li><strong>Amplified in 25% to 30% of breast cancers</strong></li>
<li><strong>Adenocarcinomas of the lung, ovary, and salivary glands</strong></li>
<li><strong>Sensitive to the mitogenic effects of small amounts of growth factors</strong></li>
<li><strong>A high level of HER2/NEU protein in breast cancer cells is a poor prognosis</strong></li>
<li><strong>Anti-HER2/NEU antibodies used in breast cancer treatment</strong></li>
</ul></li>
</ul>
</section>
<section id="downstream-signal-transducing-proteins" class="level1">
<h1>Downstream Signal-Transducing Proteins</h1>
<ul>
<li><strong>They receive signal from receptors</strong></li>
<li><strong>Carry signal to nucleus via</strong>
<ul>
<li><strong>second messengers</strong></li>
<li><strong>cascade of phosphorylation</strong></li>
</ul></li>
<li><strong>If there is an autonomy in these signals there is continuous signal to nucleus</strong></li>
<li><strong>RAS</strong></li>
<li><strong>ABL</strong></li>
</ul>
</section>
<section id="ras-protein" class="level1">
<h1>RAS protein</h1>
<ul>
<li><strong>Most commonly mutated proto-oncogene in human tumors</strong></li>
<li><strong>30% of all tumors contain RAS mutation</strong></li>
<li><strong>More common in colon and pancreas carcinoma</strong></li>
<li><strong>G protein</strong>
<ul>
<li><strong>Phosphorylation via GTP</strong></li>
</ul></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-138.png" class="img-fluid"></p>
</section>
<section id="ras" class="level1">
<h1>RAS</h1>
<ul>
<li><strong>Normally</strong>
<ul>
<li><strong>active when bound to GTP</strong></li>
<li><strong>Deactivated by GTPase</strong></li>
<li><strong>GTPase-activating proteins (GAPs)</strong></li>
</ul></li>
<li><strong>When mutated</strong>
<ul>
<li>__ cannot dephosphorylate__</li>
<li><strong>Remains active</strong></li>
</ul></li>
</ul>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-139.png" class="img-fluid"></p>
</section>
<section id="gaps" class="level1">
<h1>GAPs</h1>
<ul>
<li><strong>GTPase-activating protein</strong></li>
<li><strong>Neurofibromin-1 (NF-1)</strong>
<ul>
<li><strong>loss-of-function mutation</strong></li>
<li><strong>activation of RAS</strong></li>
<li><strong>Neurofibromatosis develops</strong></li>
</ul></li>
</ul>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-140.png" class="img-fluid"></p>
</section>
<section id="raferkmap-kinase-pathway" class="level1">
<h1>RAF/ERK/MAP kinase pathway</h1>
<p><strong>Active in 60% of melanomas</strong></p>
<p><strong>BRAF mutation seen in papillary thyroid carcinomas</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="abl" class="level1">
<h1>ABL</h1>
<ul>
<li><strong>Non-receptor-associated-tyrosine kinase</strong></li>
<li><strong>Chronic Myelogenous Leukemia</strong>
<ul>
<li><strong>ABL translocates from Chr9 to Chr22</strong></li>
<li><strong>Fuses with BCR</strong></li>
<li><strong>Continuous activation</strong></li>
<li><strong>Also activates RAS pathway</strong></li>
</ul></li>
<li><strong>Targeted therapy is present</strong>
<ul>
<li><strong>BCR-ABL kinase inhibitor (Gleevec)</strong></li>
</ul></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-141.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran’s Pathological Basis of Diseases</strong></p>
</section>
<section id="nuclear-transcription-factors" class="level1">
<h1>Nuclear Transcription Factors</h1>
<ul>
<li><strong>MYC, MYB, JUN, FOS, and REL oncogenes</strong>
<ul>
<li><strong>Regulate the expression of growth-promoting genes, such as cyclins</strong></li>
</ul></li>
</ul>
</section>
<section id="myc" class="level1">
<h1>MYC</h1>
<ul>
<li><strong>Activate growth-promoting genes cyclin-dependent kinases (CDKs)</strong></li>
<li><strong>Inhibit CDK inhibitors (CDKIs)</strong></li>
<li><strong>Upregulating genes that promote aerobic glycolysis (Warburg effect)</strong></li>
<li><strong>İncreased utilization of glutamine</strong></li>
<li><strong>Translocation</strong>
<ul>
<li><strong>t(8;14) Burkitt lymphoma</strong></li>
</ul></li>
<li><strong>Amplification</strong>
<ul>
<li><strong>Breast, colon, lung</strong></li>
<li><strong>Neuroblastomas, Small cell cancers of lung (NMYC, LMYC)</strong></li>
</ul></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-142.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran’s Pathological Basis of Diseases</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-143.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran’s Pathological Basis of Diseases</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-144.png" class="img-fluid"></p>
<p><strong>Robbins and Cotran’s Pathological Basis of Diseases</strong></p>
</section>
<section id="cyclins-and-cyclin-dependent-kinases" class="level1">
<h1>Cyclins and Cyclin-Dependent Kinases</h1>
<ul>
<li><strong>Checkpoints</strong></li>
<li><strong>G0 → G1</strong></li>
<li><strong>G1 → S</strong>
<ul>
<li><strong>Restriction point</strong></li>
<li><strong>Rate-limiting step</strong></li>
</ul></li>
</ul>
<p><strong>Checkpoints to prevent proliferation of abnormal DNA</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-145.png" class="img-fluid"></p>
<p><strong>Inhibit</strong></p>
<p><strong>tumor growth</strong></p>
<p><strong>Activate tumor growth</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Increasing expression of cyclin D or CDK4 is common in neoplasia</strong></li>
<li><strong>Cyclin D</strong>
<ul>
<li><strong>breast, esophagus, liver, and a subset of lymphomas and plasma cell tumors</strong></li>
</ul></li>
<li><strong>CDK4</strong>
<ul>
<li><strong>melanomas, sarcomas, and glioblastomas. </strong></li>
</ul></li>
<li><strong>CDKI</strong>
<ul>
<li><strong>disabled by mutation or gene silencing in many human malignancies</strong></li>
<li><strong>Germline mutations of CDKN2A</strong>
<ul>
<li><strong>25% of melanoma-prone</strong></li>
</ul></li>
<li><strong>Somatically acquired deletion or inactivation of CDKN2A</strong></li>
</ul></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-146.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="homework" class="level1">
<h1>Homework</h1>
<p><strong>Rous sarcoma virus</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-147.jpg" class="img-fluid"></p>
</section>
<section id="insensitivity-to-growth-inhibitory-signals" class="level1">
<h1>INSENSITIVITY TO GROWTH INHIBITORY SIGNALS</h1>
<p><strong>Tumor Supressor Genes</strong></p>
</section>
<section id="rb-gene-governor-of-the-cell-cycle" class="level1">
<h1>RB Gene: Governor of the Cell Cycle</h1>
<ul>
<li><strong>13q14</strong></li>
<li><strong>Retinoblastoma occurs as a similar disease both in sporadic and familial forms</strong></li>
<li><strong>Familial disease is Autosomal Dominant trait</strong></li>
<li><strong>RB gene homozygous loss in</strong>
<ul>
<li><strong>breast cancer, small cell cancer of the lung, and bladder cancer</strong></li>
</ul></li>
<li><strong>Patients with retinoblastoma have increased risk of</strong>
<ul>
<li><strong>Osteosarcoma and soft tissue sarcomas</strong></li>
</ul></li>
</ul>
</section>
<section id="retinoblastoma" class="level1">
<h1>Retinoblastoma</h1>
<p><img src="img%5CHallmarks-of-Cancer-148.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-149.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-150.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-151.jpg" class="img-fluid"></p>
<p><strong>Figure 2, from Pediatr Radiol. Jun 2012; 42(6): 738–749. PMCID: PMC3530407</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-152.jpg" class="img-fluid"></p>
<p><strong>Figure 7.4b </strong> _ The Biology of Cancer_ __ (© Garland Science 2007)__</p>
</section>
<section id="knudson-two-hit-hypothesis" class="level1">
<h1>Knudson two-hit hypothesis</h1>
<p><img src="img%5CHallmarks-of-Cancer-153.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-154.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="does-a-cell-become-neoplastic-when-one-rb-gene-is-mutated" class="level1">
<h1>Does a cell become neoplastic when one Rb gene is mutated?</h1>
<p><strong>No</strong></p>
<p><strong>Tumor Suppressor Genes require loss of function of both alleles to become neoplastic</strong></p>
<p><strong>Which mechanisms cause loss of function in a gene?</strong></p>
<p><strong>Does a cell become neoplastic when one allele of proto-oncogene is mutated?</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-155.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-156.png" class="img-fluid"></p>
<p><strong>cyclin E transcription</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-157.png" class="img-fluid"></p>
<p><strong>HPV E7 protein mimics here</strong></p>
<p><strong>cyclin E transcription</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-158.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-159.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-160.png" class="img-fluid"></p>
</section>
<section id="tp53-gene-guardian-of-the-genome" class="level1">
<h1>TP53 GeneGuardian of the Genome</h1>
<ul>
<li><strong>Quiescence</strong>
<ul>
<li><strong>Activation of temporary cell cycle arrest</strong></li>
</ul></li>
<li><strong>Senescence</strong>
<ul>
<li><strong>Induction of permanent cell cycle arrest</strong></li>
</ul></li>
<li><strong>Apoptosis</strong>
<ul>
<li><strong>Triggering of programmed cell death</strong></li>
</ul></li>
</ul>
<p><strong>Rb “senses” external signals, p53 monitors internal stress</strong></p>
</section>
<section id="p53-is-activated-by" class="level1">
<h1>p53 is activated by</h1>
<p><strong>Anoxia</strong></p>
<p><strong>Inappropriate oncoprotein activity</strong></p>
<p><strong>Damage to the integrity of DNA</strong></p>
<p><strong>p53 is a DNA damage response protein</strong></p>
</section>
<section id="p53" class="level1">
<h1>p53</h1>
<ul>
<li><strong>Normally</strong>
<ul>
<li><strong>p53 has a short half-life</strong></li>
<li><strong>After 20 minutes associates with MDM2 and destructed</strong></li>
</ul></li>
<li><strong>When cell is stressed</strong>
<ul>
<li><strong>Protein kinases are activated</strong>
<ul>
<li><strong>ATM (ataxia telangiectasia mutated)</strong></li>
</ul></li>
<li><strong>Make post transcriptional modifications in p53</strong></li>
<li><strong>p53 is released from MDM2</strong></li>
<li><strong>p53 activity continues</strong></li>
</ul></li>
<li><strong>After repair</strong>
<ul>
<li><strong>p53 induces MDM2 expression and p53 levels decrease to normal, cell cycle continues</strong></li>
</ul></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-161.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="p53-mediated-cell-cycle-arrest" class="level1">
<h1>p53-mediated cell cycle arrest</h1>
<p><strong>p53 induces transcription of CDKI gene CDKN1A (p21)</strong></p>
<p><strong>p21 protein inhibits cyclin–CDK complexes</strong></p>
<p><strong>Prevents phosphorylation of Rb</strong></p>
<p><strong>Arresting cells in the G1 phase</strong></p>
<p><strong>Time to repair DNA damage</strong></p>
</section>
<section id="p53-induced-senescence" class="level1">
<h1>p53-induced senescence</h1>
<p><strong>Involve global chromatin changes</strong></p>
<p><strong>Drastically and permanently alter gene expression</strong></p>
<p><strong>Permanent cell cycle arrest</strong></p>
</section>
<section id="p53-induced-apoptosis" class="level1">
<h1>p53-induced apoptosis</h1>
<p><strong>Irreversible DNA damage</strong></p>
<p><strong>pro-apoptotic genes such as BAX and PUMA</strong></p>
</section>
<section id="p53-1" class="level1">
<h1>p53</h1>
<ul>
<li><strong>70% of human cancers have a biallelic loss in p53</strong></li>
<li><strong>Others have defects in genes upstream or downstream of TP53</strong></li>
<li><strong>p53 is inhibited by oncogenic DNA viruses</strong>
<ul>
<li><strong>Hepatitis B virus</strong></li>
<li><strong>possibly EBV</strong></li>
</ul></li>
</ul>
</section>
<section id="li-fraumeni-syndrome" class="level1">
<h1>Li-Fraumeni syndrome</h1>
<p><strong>Inherit a mutant TP53 allele</strong></p>
<p><strong>25x more cancer by age 50</strong></p>
<p><strong>Sarcomas, breast cancer, leukemia, brain tumors, carcinomas of the adrenal cortex</strong></p>
<p><strong>Younger age</strong></p>
<p><strong>Multiple primary tumors</strong></p>
</section>
<section id="transforming-growth-factor-β-pathway" class="level1">
<h1>Transforming Growth Factor-β Pathway</h1>
<ul>
<li><strong>Potent inhibitor of proliferation</strong></li>
<li><strong>TGF-β receptors I and II</strong>
<ul>
<li><strong>Activate with dimerization</strong></li>
</ul></li>
<li><strong>Growth-suppressing activity</strong>
<ul>
<li><strong>Transcriptional activation of CDKIs</strong></li>
</ul></li>
<li><strong>Repression of growth-promoting genes </strong>
<ul>
<li><strong>MYC, CDK2, CDK4</strong></li>
<li><strong>Encoding cyclins A and E</strong></li>
</ul></li>
<li><strong>SMAD molecules</strong>
<ul>
<li><strong>Transduce antiproliferative signals from the receptor to the nucleus</strong></li>
</ul></li>
<li><strong>TGF-β signaling activates epithelial-to-mesenchymal transition (EMT)</strong></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-162.jpg" class="img-fluid"></p>
<p><strong>Figure 5.21 </strong> _ The Biology of Cancer_ __ (© Garland Science 2007)__</p>
</section>
<section id="transforming-growth-factor-β-pathway-alterations" class="level1">
<h1>Transforming Growth Factor-β Pathway Alterations</h1>
<ul>
<li><strong>Mutations in</strong>
<ul>
<li><strong>Type II TGF-β receptor</strong>
<ul>
<li><strong>colon, stomach, and endometrium cancers</strong></li>
</ul></li>
<li><strong>SMAD molecules</strong>
<ul>
<li><strong>SMAD4 in pancreatic cancers</strong></li>
</ul></li>
</ul></li>
<li><strong>100% of pancreatic cancers and 83% of colon cancers, at least one component of the TGF-β pathway is mutated</strong></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-163.jpg" class="img-fluid"></p>
<p><strong>Figure 6.29d </strong> _ The Biology of Cancer_ __ (© Garland Science 2007)__</p>
</section>
<section id="contact-inhibition" class="level1">
<h1>Contact Inhibition</h1>
<ul>
<li><strong>Nontransformed cells are grown in culture</strong>
<ul>
<li><strong>Proliferate until confluent monolayers are generated</strong></li>
<li><strong>Cell–cell contacts formed in these monolayers suppress further cell proliferation</strong></li>
</ul></li>
<li><strong>In cancer cells</strong>
<ul>
<li><strong>No contact inhibition</strong></li>
<li><strong>Proliferate and pile on top of one another</strong></li>
</ul></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-164.png" class="img-fluid"></p>
<p><strong>Figure 3.7 from The Biology Of Cancer (2007) - Weinberg</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-165.jpg" class="img-fluid"></p>
<p><strong>Figure 3.7a </strong> _ The Biology of Cancer_ __ (© Garland Science 2007)__</p>
<p><img src="img%5CHallmarks-of-Cancer-166.jpg" class="img-fluid"></p>
<p><strong>Figure 3.12 </strong> _ The Biology of Cancer_ __ (© Garland Science 2007)__</p>
<p><img src="img%5CHallmarks-of-Cancer-167.png" class="img-fluid"></p>
<p><strong>Figure 3.7 from The Biology Of Cancer (2007) - Weinberg</strong></p>
</section>
<section id="e-cadherin" class="level1">
<h1>E-cadherin</h1>
<ul>
<li><strong>E-cadherin mediates cell–cell contact in epithelial layers</strong></li>
<li><strong>Tumor suppressor gene NF2 (neurofibromin-2, merlin), facilitates E-cadherin mediated contact inhibition</strong></li>
<li><strong>Homozygous loss of NF2 → neural tumors</strong>
<ul>
<li><strong>Neurofibromatosis</strong></li>
</ul></li>
<li><strong>E-cadherin is also regulated by APC (adenomatous polyposis coli gene)</strong></li>
</ul>
<p><strong>No APC is present</strong></p>
<p><strong>β-Catenin is active independent of WNT status</strong></p>
<p><strong>WNT signal inhibits APC</strong></p>
<p><strong>β-Catenin enters nucleus</strong></p>
<p><strong>APC is active</strong></p>
<p><strong>β-Catenin is dectructed</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-168.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>No APC is present</strong></p>
<p><strong>β-Catenin is active independent of WNT status</strong></p>
<p><strong>WNT signal inhibits APC</strong></p>
<p><strong>β-Catenin enters nucleus</strong></p>
<p><strong>APC is active</strong></p>
<p><strong>β-Catenin is dectructed</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-169.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-170.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-171.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-172.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-173.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-174.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-175.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-176.jpg" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-177.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-178.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-179.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-180.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-181.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-182.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-183.png" class="img-fluid"></p>
<p><img src="img%5CHallmarks-of-Cancer-184.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>β-Catenin is active in the nucleus</strong></p>
<p><img src="img%5CHallmarks-of-Cancer-185.png" class="img-fluid"></p>
<p><strong>cyclin D1 and MYC transcribed for proliferation</strong></p>
<p><strong>TWIST and SLUG are expressed</strong></p>
<p><strong>They repress E-cadherin expression</strong></p>
<p><strong>Reduce contact inhibition</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="adenomatous-polyposis-coli" class="level1">
<h1>Adenomatous Polyposis Coli</h1>
<ul>
<li><strong>APC is a tumor suppressor gene</strong></li>
<li><strong>With one mutant allele</strong>
<ul>
<li><strong>Hundreds to thousands of adenomatous polyps in the colon</strong></li>
<li><strong>By age 20s</strong></li>
</ul></li>
<li><strong>When other allele also mutated</strong>
<ul>
<li><strong>Malignant transformation</strong></li>
</ul></li>
<li><strong>APC mutations are seen in 70% to 80% of sporadic colon cancers</strong></li>
<li><strong>Colonic cancers with normal APC genes have activating mutations of β-catenin</strong>
<ul>
<li><strong>Refractory to the degrading action of APC</strong></li>
</ul></li>
</ul>
<p><img src="img%5CHallmarks-of-Cancer-186.jpg" class="img-fluid"></p>
<p><strong>Figure 7.22 </strong> _ The Biology of Cancer_ __ (© Garland Science 2007)__</p>
<p><img src="img%5CHallmarks-of-Cancer-187.jpg" class="img-fluid"></p>
<p><strong>Figure 7.24a </strong> _ The Biology of Cancer_ __ (© Garland Science 2007)__</p>
</section>

</main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>